Skip to main content

Blog

Capricor Therapeutics Announces Positive 3-Year Efficacy Results from HOPE-2 Open Label Extension Study of CAP-1002

...

NS Pharma Shares Update on VILTEPSO® (Viltolarsen) Phase 3 Study

...

Dyne Therapeutics Shares New Clinical Data from DELIVER Trial of DYNE-251 in Duchenne Patients

...

Study to Explore Barriers to Diverse Clinical Trial Participation in Duchenne Published

...

PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation

...

Congress Passes FAA Reauthorization Featuring Monumental Accessibility Improvements

...

Mapping Out a Path Forward: PPMD Convenes Representatives from 21 Academic Centers and 11 Industry Partners for 2024 Cardiac Care Workshop

...

PPMD’s Pat Furlong Honored with ASGCT’s Sonia Skarlatos Public Service Award

...

Updates from the ACHDNC Meeting and Next Steps for Duchenne Newborn Screening

...

PPMD Hosts 2024 Cardiac Workshop, May 9-10

...